Clinical trials
Heavy Drinker clinical trials
Below are recruiting heavy drinker clinical trials, each written for real people, not researchers. We’re tracking 7 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06136195RecruitingPhase 1
Mavoglurant for alcohol craving in heavy drinkers
This trial tests whether a medication called mavoglurant can reduce alcohol cravings and drinking in people who are heavy drinkers with alcohol use disorder and are not looking for treatment.
New Haven, ConnecticutAges 21–50 - NCT07516873Recruiting
Mindfulness and Nerve Stimulation for Young Adults Drinking Heavily
This study tests whether brief mindfulness training combined with a mild electrical stimulation device on the ear can help reduce cravings and urges to drink alcohol in people aged 21–29 who drink heavily. The goal is to understand if this combination approach works better than either alone.
Malden, MassachusettsAges 21–29 - NCT04781322RecruitingPhase 1
Study drug to reduce LDL cholesterol effects in heavy drinkers
This Phase 1 study tests how safe a cholesterol-lowering antibody (alirocumab) is in people who drink heavily but are not seeking alcohol treatment. It also looks at early drug effects in the body to see how it might change cholesterol-related signals.
Bethesda, MarylandAges 21–65 - NCT05491551Recruiting
Alcohol training program to help you cut back or quit
This study tests a structured training program for young adults who’ve been drinking heavily, to help them reduce drinking or quit. You’ll be asked to complete daily short check-ins and follow study instructions, and you may be randomly assigned to different parts of the program.
Berkeley, CaliforniaAges 18–26 - NCT06584448Recruiting
Drinking, acetate, and stress study
This study looks at how acetate (a substance produced when the body breaks down alcohol) affects stress and drinking. It tests if giving acetate can help people with alcohol use disorder (AUD) reduce their drinking.
New Haven, ConnecticutAges 18–60 - NCT04088370Recruiting
Testing blood immune cell response in alcohol-related liver disease
This study looks at how immune cells in the blood respond in people with alcoholic hepatitis and in people who drink heavily (with no known liver disease). It may help researchers understand why liver inflammation happens after heavy alcohol use.
Cleveland, OhioAges 21–65 - NCT07277673Recruiting
Exercise plus talk therapy for impotence in men with metabolic syndrome
This trial tests if adding aerobic exercise to cognitive behavioral therapy (talk therapy) can help treat impotence in men who have metabolic syndrome and drink heavily.
Giza, DokkiAges 35–45
Hear when a new Heavy Drinker trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Heavy Drinker trials by city
Studies with a site in or near these metro areas.
Heavy Drinker trials by state
Studies with a site anywhere in these states.
Common questions
- Are there clinical trials for heavy drinker?
- Yes. Clin2 currently lists 7 recruiting heavy drinker studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a heavy drinker trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a heavy drinker trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.